|
FORM 10-Q
EX 11.1
<PAGE>
EXHIBIT 11.1
BIOPSYS MEDICAL, INC.
STATEMENT RE: COMPUTATION OF NET INCOME (LOSS) PER SHARE
<TABLE>
<CAPTION>
Three Months Ended Six Months Ended
December 31, December 31,
-------------------------- --------------------------
1996 1995 1996 1995
----------- ---------- ----------- -----------
<S> <C> <C> <C> <C>
Net income (loss) $ 144,000 $ (897,000) $ 5,000 $(1,514,000)
----------- ---------- ----------- -----------
----------- ---------- ----------- -----------
Shares used in computing net income (loss) per share:
Weighted average common shares outstanding during the period 9,758,565 1,785,000 9,737,722 1,762,218
Equivalent shares representing
shares issuable upon conversion of
preferred stock and preferred warrants:
Series A - 833,333 - 833,333
Series B - 1,333,333 - 1,333,333
Series C - 3,051,590 - 3,051,590
Series C warrants - 32,624 - 32,624
Equivalent shares representing
shares issuable upon conversion
of common stock options 1,296,410 556,902 1,245,635 556,902
----------- ---------- ----------- -----------
Total shares used in computing
historical net income (loss) per
share 11,054,975 7,592,782 10,983,357 7,570,000
----------- ---------- ----------- -----------
----------- ---------- ----------- -----------
Net income (loss) per share $ 0.01 $ (0.12) $ 0.00 $ (0.20)
----------- ---------- ----------- -----------
----------- ---------- ----------- -----------
</TABLE>
15
EX 27
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED BALANCE SHEET AND STATEMENT OF OPERATIONS CONTAINED IN THE BIOPSYS
MEDICAL, INC. FORM 10Q FOR THE SIX MONTHS ENDED DECEMBER 31, 1996 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> JUN-30-1997
<PERIOD-START> JUL-01-1996
<PERIOD-END> DEC-31-1996
<CASH> 7,019,000
<SECURITIES> 8,790,000
<RECEIVABLES> 2,414,000
<ALLOWANCES> (97,000)
<INVENTORY> 2,386,000
<CURRENT-ASSETS> 21,073,000
<PP&E> 1,211,000
<DEPRECIATION> (225,000)
<TOTAL-ASSETS> 41,005,000
<CURRENT-LIABILITIES> 1,697,000
<BONDS> 0
<PREFERRED-MANDATORY> 0
<PREFERRED> 0
<COMMON> 10,000
<OTHER-SE> 39,298,000
<TOTAL-LIABILITY-AND-EQUITY> 41,005,000
<SALES> 5,703,000
<TOTAL-REVENUES> 5,703,000
<CGS> 2,510,000
<TOTAL-COSTS> 2,510,000
<OTHER-EXPENSES> 4,141,000
<LOSS-PROVISION> 25,000
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 5,000
<INCOME-TAX> 0
<INCOME-CONTINUING> 5,000
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 5,000
<EPS-PRIMARY> 0
<EPS-DILUTED> 0
</TABLE>
|
